State-of-the-art technology for cancer therapy.
For the treatment of Tomorrow.
Sustainable
We are scaling up the production of radionuclides for cancer therapy (radioligand therapy). To do this, we use particle accelerators, thus using electricity instead of research or nuclear reactors, and recycle our starting material.
Safe
Our accelerators are in a safe radiation protection environment and pose no safety risk. Our processes allow GMP products with very high levels of purity and thus protect patients.
Accessible
LinaThera makes radionuclides for radioligand therapy accessible on a large scale – for research, development and, above all, for reliable patient care.
Feasibility study
Sustainable healthcare as a driver of innovation for northern Bavaria.
We would like to thank the district of Forchheim and Medical Valley Forchheim for their support with this feasibility study. It is a joint effort, the result of a close exchange between research, industry and our partners. The study is intended to appeal to decision-makers from politics and society and lay the foundations for establishing Northern Bavaria as a region of progress for innovative and responsible cancer therapies in nuclear medicine.
We make modern cancer therapy accessible through sustainable, safe production of radioisotopes in a stand-alone facility – expandable and replicable.
Nothing Found
Our partners
